NAVB
Navidea Biopharmaceuticals Inc.
NAVB
NAVB
Delisted
NAVB was delisted on the 5th of October, 2023.
74 hedge funds and large institutions have $46.7M invested in Navidea Biopharmaceuticals Inc. in 2016 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 17 increasing their positions, 20 reducing their positions, and 12 closing their positions.
Holders
74
Holders Change
-4
Holders Change %
-5.13%
% of All Funds
1.97%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
8
Increased
17
Reduced
20
Closed
12
Calls
$65K
Puts
$85K
Net Calls
-$20K
Net Calls Change
+$7.97M
Top Buyers
| 1 |
PM
1
Platinum Management
New York
|
$14.7M |
| 2 |
2
D.E. Shaw & Co
New York
|
$191K |
| 3 |
3
SG Americas Securities
New York
|
$92K |
| 4 |
4
Citigroup
New York
|
$122K |
| 5 |
RFC
5
Russell Frank Company
Seattle,
Washington
|
$67K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
VKH
76
Virtu KCG Holdings
New York
| – | -$138K | -5,204 | Closed |
|
77
Millennium Management
New York
| – | -$106K | -3,968 | Closed |
|
|
ARTA
78
A.R.T. Advisors
New York
| – | -$62K | -2,359 | Closed |
|
79
BNP Paribas Financial Markets
Paris,
France
| – | -$38.7K | -1,455 | Closed |
|
|
RCM
80
Rotella Capital Management
Bellevue,
Washington
| – | -$30K | -1,120 | Closed |
|
|
TRCT
81
Tower Research Capital (TRC)
New York
| – | -$23K | -874 | Closed |
|
|
TSS
82
Two Sigma Securities
New York
| – | -$20K | -752 | Closed |
|
|
GC
83
Guggenheim Capital
Chicago,
Illinois
| – | -$20K | -745 | Closed |
|
|
IA
84
IFP Advisors
Tampa,
Florida
| – | -$3K | -100 | Closed |
|
85
Simplex Trading
Chicago,
Illinois
| – | -$1K | -40 | Closed |
|